Skip to main content

Table 4 Overall survival

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

 

Low

Intermediate

High

Months

% Alive

No. at Risk

% Alive

No. at Risk

% Alive

No. at Risk

0

100%

17

100%

70

100%

66

12

59%

10

49%

34

48%

32

24

29%

5

16%

11

12%

8

36

18%

3

5%

3

5%

3

48

12%

1

0

0

2%

1

60

12%

1

0

0

2%

1

Median Dead/Total

13.3 mo. 16/17

11.8 mo. 69/70

11.6 mo. 65/66

  1. Pairwise Comparisons using Log-rank test: Low vs. Intermediate (0.18), Low vs. High (0.16), Intermediate vs. High (0.80).